Loading…

Activation of the PKB/AKT Pathway by ICAM-2

We identified intracellular adhesion molecule-2 (ICAM-2) in a genetic screen as an activator of the PI3K/AKT pathway leading to inhibition of apoptosis. ICAM-2 induced tyrosine phosphorylation of ezrin and PI3K kinase membrane translocation, resulting in phosphatidylinositol 3,4,5 production, PDK-1...

Full description

Saved in:
Bibliographic Details
Published in:Immunity (Cambridge, Mass.) Mass.), 2002, Vol.16 (1), p.51-65
Main Authors: Perez, Omar D, Kinoshita, Shigemi, Hitoshi, Yasumichi, Payan, Donald G, Kitamura, Toshio, Nolan, Garry P, Lorens, James B
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We identified intracellular adhesion molecule-2 (ICAM-2) in a genetic screen as an activator of the PI3K/AKT pathway leading to inhibition of apoptosis. ICAM-2 induced tyrosine phosphorylation of ezrin and PI3K kinase membrane translocation, resulting in phosphatidylinositol 3,4,5 production, PDK-1 and AKT activation, and subsequent phosphorylation of AKT targets BAD, GSK3, and FKHR. ICAM-2 clustering protected primary human CD19 + cells from TNFα- and Fas-mediated apoptosis as determined by single-cell analysis. ICAM-2 engagement by CD19 + cells of its natural receptor, LFA-1, on CD4 + naive cells specifically induced AKT activity in the absence of an MHC-peptide interaction. These results attribute a novel signaling function to ICAM-2 that might suggest mechanisms by which ICAM-2 signals intracellular communication at various immunological synapses.
ISSN:1074-7613
1097-4180
DOI:10.1016/S1074-7613(02)00266-2